The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
β-Catenin destruction complex: insights and questions from a structural perspective
Abstract
At the heart of the canonical Wnt signaling pathway is the beta-catenin destruction complex, which functions in the absence of Wnt signaling to keep the cytosolic and nuclear levels of beta-catenin very low by promoting the phosphorylation and ubiquitination of beta-catenin. Structural studies, combined with other experimental approaches, have begun to provide important insights into the mechanism of the destruction complex. We suggest a working model for the destruction complex based on the existing structural and experimental data, and focus on the questions that this model and other studies have raised about the function of the complex in both the normal and Wnt-inhibited states.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Next, the β-catenin proteins undergo proteasomal destruction [259, 260], which is greatly accelerated by the presence of IDRs in addition to the bound ubiquitin signal [262].”
From Intrinsically disordered proteins play diverse roles in cell signaling (2022) · cites this paper as [260]
In the citing paper
“Prior to Wnt signaling, the transcription factor β-catenin is maintained at low levels by the β-catenin destruction complex, which is an assembly of the 852 residue mostly disordered scaffold protein axin, the 2,843 residue massively disordered protein adenomatous polyposis coli (APC), and the three mostly structured proteins β-catenin, casein kinase Ia (CKI-a), and glycogen synthetase kinase 3b (”
From Intrinsically disordered proteins play diverse roles in cell signaling (2022) · cites this paper as [260]
In the citing paper
“The two kinases phosphorylate residues within a long IDR at β-catenin’s amino terminus [259, 260].”
From Intrinsically disordered proteins play diverse roles in cell signaling (2022) · cites this paper as [260]
Citations
Cites
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semënov, M. V., Han, C., Baeg, G., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,152
WNT and β-catenin signalling: diseases and therapies
Moon, R. T., Kohn, A. D., Ferrari, G. V. D., & Kaykas, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1427 · Cited by 1,763
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,493
Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., & Kikuchi, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1371 · Cited by 1,248
Mao, J., Wang, J., Liu, B., Pan, W., Farr, G. H., Flynn, C., Yuan, H., Takada, S., Kimelman, D., Li, L., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00224-6 · Cited by 839 · cited 4×
“For example, as discussed above, under certain conditions LRP5/6 can function in a Frizzled and Dishevelled-independent manner whereas normally all of these components function synergistically (Li et al., 2002; Schweizer and Varmus, 2003; Cong et al., 2004b).”
BackgroundInfluentialSelf-citationAxin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathwayPreprint
Amit, S., Hatzubai, A., Birman, Y., Andersen, J., Ben-Shushan, E., Mann, M., Ben‐Neriah, Y., & Alkalay, I. (2002) · Genes & Development · doi:10.1101/gad.230302 · Cited by 784
Huber, A. H., & Weis, W. I. (2001) · Cell · doi:10.1016/s0092-8674(01)00330-0 · Cited by 777
Three-Dimensional Structure of the Armadillo Repeat Region of β-Catenin
Huber, A. H., Nelson, W. J., & Weis, W. I. (1997) · Cell · doi:10.1016/s0092-8674(00)80352-9 · Cited by 727
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 631
Banskota, S., Dahal, S., Kwon, E., Kim, D. Y., & Kim, J. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0391-7 · Cited by 16
Koujah, L., Madavaraju, K., Agelidis, A. M., Patil, C. D., & Shukla, D. (2021) · mBio · doi:10.1128/mbio.02792-21 · Cited by 15
Bioengineered Hierarchical Bonelike Compartmentalized Microconstructs Using Nanogrooved Microdiscs
Bjørge, I. M., de Sousa, B. M., Patrício, S. G., Silva, A. S., Nogueira, L. P., Santos, L. F., Vieira, S. I., Haugen, H. J., Correia, C. R., & Mano, J. F. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c01161 · Cited by 15
Kohler, E. M., Brauburger, K., Behrens, J., & Schneikert, J. (2009) · Oncogene · doi:10.1038/onc.2009.447 · Cited by 16
“In the absence of a wnt signal, b-catenin is destroyed in the proteasome where it is conveyed only after a critical phosphorylation step catalysed in the so-called degradation complex (Kimelman and Xu, 2006).”
BackgroundWnt target gene activation requires β-catenin separation into biomolecular condensates
Stewart, R. A., Ding, Z., Jeon, U. S., Goodman, L., Tran, J. J., Zientko, J. P., Sabu, M., & Cadigan, K. M. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002368 · Cited by 14
Zeller, J., Turbiak, A. J., Powelson, I. A., Lee, S., Sun, D., Showalter, H. D., & Fearon, E. R. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.111 · Cited by 14
S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway
Yang, W., Nam, K., Ju, J., Lee, K., Oh, S., & Shin, I. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.06.007 · Cited by 14
Alexandrova, E. M., & Sokol, S. Y. (2009) · Developmental Dynamics · doi:10.1002/dvdy.22125 · Cited by 14
“marked for proteasomal degradation by the b-catenin destruction complex that consists of glycogen synthase kinase 3b (GSK3b) and two scaffold proteins: Adenomatous polyposis coli (APC) and Axin (Ikeda et al., 1998; Itoh et al, 1998; Kimelman and Xu, 2006).”
BackgroundUVB represses melanocyte cell migration and acts through β‐catenin
Bertrand, J. U., Petit, V., Hacker, E., Berlin, I., Hayward, N. K., Pouteaux, M., Sage, É., Whiteman, D. C., & Larue, L. (2017) · Experimental Dermatology · doi:10.1111/exd.13318 · Cited by 14
Dimova, N., Wysoczynski, M., & Rokosh, G. D. (2013) · Stem Cells · doi:10.1002/stem.1534 · Cited by 14
Křı́ž, V., Pospíchalová, V., Mašek, J., Kilander, M. B. C., Slavík, J., Tanneberger, K., Schulte, G., Machala, M., Kozubı́k, A., Behrens, J., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.498444 · Cited by 14
Molecular piracy: manipulation of the ubiquitin system by Kaposi's sarcoma‐associated herpesvirus
Fujimuro, M., Hayward, S. D., & Yokosawa, H. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.549 · Cited by 14
“-catenin level is regulated by GSK-3 kinase, which phosphorylates -catenin and targets it for K48-linked polyubiquitination and subsequently for proteasomal degradation [97,98].”
BackgroundFontana, C. M. L., Zyla, L. E., Santiano, F. E., Sasso, C. V., Cuello-Carrión, F. D., Creydt, V. P., Fanelli, M. A., & Carón, R. W. (2017) · Histochemistry and Cell Biology · doi:10.1007/s00418-017-1544-x · Cited by 14
“It is recognized by the destruction complex integrated by the molecules Axin, adenomatous polyposis coli (APC), casein kinase 1 (CK1) and glycogen synthase kinase 3β (GSK3β) which phosphorylate β-catenin in a sequential way to be rapidly targeted for degradation (Kimelman and Xu 2006).”
BackgroundLiu, Z.-H., Yang, Y., Ge, M.-M., Xu, L., Tang, Y., Hu, F., Xu, Y., & Wang, H.-L. (2015) · Toxicology Research · doi:10.1039/c4tx00093e · Cited by 14
“Environ Sci Technol 2011;45(21):9372-9.”
The Usher syndrome 1C protein harmonin regulates canonical Wnt signaling
Schäfer, J., Wenck, N., Janik, K., Linnert, J., Štingl, K., Kohl, S., Nagel‐Wolfrum, K., & Uwe Wolfrum, B. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1130058 · Cited by 13
“Cytoplasmic β-catenin molecules are phosphorylated by the activity of the destruction complex and subsequently targeted for ubiquitination and proteosomal degradation (Kimelman and Xu, 2006) (see below summary Figures 8A, B).”
BackgroundSolberg, N. T., Melheim, M., Strand, M. F., Olsen, P. A., & Krauss, S. J. K. (2019) · Cancers · doi:10.3390/cancers11020164 · Cited by 14
“The GSK3β containing β-catenin destruction complex is stabilized by both APC and axis inhibition protein 1 and 2 (AXIN1/2) in the absence of canonical WNT signals, promoting proteasomal degradation of both β-catenin (reviewed by [8]) and a subset of RAS proteins [7].”
BackgroundThe Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research
Sun, M., Chen, Z., Wu, X., Yu, Y., Wang, L., Lü, A., Zhang, G., & Li, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.602330 · Cited by 14
“As soon as Wnt-Fz-LRP5/6 complex is formed, the Axinmediated destruction complex would translocate to the plasma membrane via being phosphorylated by other proteins within the destruction complex, thereby inhibiting the phosphorylation of b-catenin (38, 39).”
BackgroundLei, W., Li, Y., Meng, T., Ning, Y., Sun, S., Zhang, C., Gui, Y., Wang, Z., Qian, W., & Sun, Q. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04172-y · Cited by 13
“The E3 ubiquitin ligase β-Trcp can bind β-catenin at serine 33 and 37 when the two sites were phosphorylated, finally leading to β-catenin ubiquitination and degradation [40].”
BackgroundTargeted β‐catenin ubiquitination and degradation by multifunctional stapled peptides
Wang, X., Dong, L., Cheng, J., Verdine, G. L., Lin, A., & Chu, Q. (2021) · Journal of Peptide Science · doi:10.1002/psc.3389 · Cited by 13
Xu, H., Liu, Y., Liu, S., Miao, Y., Li, Q., & Wang, E. (2013) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-013-1375-7 · Cited by 13
“Its activation has been noted inmany cancers and promotes proliferation, dedifferentiation, invasion andmetastasis of cancers, including ovarian cancers [26–30].”
BackgroundCosta, Â. M. S., Pereira-Castro, I., Ricardo, E., Spencer, F., Fisher, S., & Costa, L. T. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067694 · Cited by 13
“In the absence of Wnt, β-catenin phosphorylation targets it for degradation in the proteasome [41,42], freeing TCF proteins to participate in transcription repression [12,43–46].”
BackgroundXu, H., Li, Q., Dai, S., Xie, X., LIU, D., & Wang, E. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02799.x · Cited by 13
“(APC), and is targeted for ubiquitin-mediated proteasomal degradation to maintain cytoplasmic b-catenin at a low level (2).”
BackgroundMechanical Stretch and Cytokines
Henrotin, Y., Pesesse, L., & Sanchez, C. (2011) · Springer eBooks · doi:10.1007/978-94-007-2004-6 · Cited by 14
Díaz, A., Martín-Jiménez, C., Xu, Y., Merino, P., Woo, Y., Torre, E. R., & Yepes, M. (2021) · Journal of Cell Science · doi:10.1242/jcs.255919 · Cited by 13
The functions of long non-coding RNAs in colorectal cancer
Wang, H., Huang, C., & Yao, X. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.08.23 · Cited by 13
“Casein kinase 1 (CK1), glycogen synthase kinase 3β (GSK3β), Axin, protein phosphatase 2A (PP2A), and APC and activator protein 2α (AP-2α) are all significant in the Wnt signalling pathway (9).”
BackgroundJiang, F., Du, L., Chen, Z., Wang, X., Ge, D., & Liu, N. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00276 · Cited by 12
Tsai, Y.-W., Tseng, Y.-S., Wu, Y., Song, W., You, M.-Y., Hsu, Y.-C., Chen, W., Huang, W., Chng, J.-C., Lim, C.-L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56216-y · Cited by 12
“The levels of activated glycogen synthase kinase 3 β (GSK3 β , phosophor-Y216), a key component of the β -Catenin destruction complex 35 , were similar between α MHC-Cdh2 fl /+ and control mouse heart, excluding its involvement in N-Cadherin-dependent β -Catenin regulation (Fig.”
Terra, M. L., Sant’Anna, T. B. F., de Barros, J. J. F., & Araujo, N. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072889 · Cited by 13
“Once in the nucleus, β -catenin acts as a co-activator of transcription factors [79,80]. β -catenin is a multifunctional protein encoded by the CTNNB1 gene, located on chromosome 3p22.”
Terawaki, S., Fujita, S., Katsutani, T., Shiomi, K., Keino‐Masu, K., Masu, M., Wakamatsu, K., Shibata, N., & Higuchi, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-08019-5 · Cited by 12
Li, S., Ghaleb, A. M., He, J., Bughani, U., Bialkowska, A. B., Yang, V. W., & Joshi, H. C. (2011) · International Journal of Cancer · doi:10.1002/ijc.27344 · Cited by 12
“Tcf4/b-catenin is responsible for activating an array of downstream genes such as cyclin D1 and c-Myc via specific Tcf-responsive elements.32 The cytoplasmic levels of b-catenin are maintained by exquisite regulation of its degradation mediated by APC signaling complexes assembled on cellular MTs via a MT plus end tra…”
BackgroundFischer, V., Brown‐Grant, D., & Li, F. (2012) · Journal of Molecular Signaling · doi:10.1186/1750-2187-7-6 · Cited by 12
β-Catenin: Structure, Function and Role in Malignant Transformation of Epithelial Cells
Isaeva, A. V., Zima, A. P., Петровна, Ш. И., Ryazantsevа, N. V., Васильева, О. А., Kasoayn, K. T., Саприна, Т. В., Латыпова, В. Н., Сергеевна, Б. И., & Новицкий, В. В. (2015) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v70.i4.1415 · Cited by 12
Lins, R. R., Oshima, C. T. F., de Oliveira, L. A., Silva, M. D. S., Mader, A. M. A. A., Waisberg, J., & UNIFESP, B. (2016) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-6720201600040004 · Cited by 12
Role of Nurr1 in Carcinogenesis and Tumor Immunology: A State of the Art Review
Wan, P. K.-T., Siu, M. K.-Y., Leung, T. H.-Y., Mo, X.-T., Chan, K. K. L., & Ngan, H. (2020) · Cancers · doi:10.3390/cancers12103044 · Cited by 12
“Its level is regulated by the β-catenin destru tio co plex, particularly by the ade omatous polyposis coli (APC) protein [69].”
BackgroundPygo1 regulates pathological cardiac hypertrophy via a β-catenin-dependent mechanism
Lin, L., Xu, W., Li, Y., Zhu, P., Yuan, W., Ming, L., Shi, Y., Chen, Y., Liang, J., Chen, J., et al. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00538.2020 · Cited by 12
Self-citationLiver regeneration: unraveling the molecular mechanisms and clinical application
Wang, N., Guo, M., Zhang, C., Jiang, R., Bi, J., Sun, J., & Liu, B. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07412-3 · Cited by 15
“In the absence of Wnt signaling, β-catenin forms a degradation complex with Axin, adenomatous polyposis coli (APC), glycogen synthase kinase 3β (GSK3β), and casein kinase 1α (CK1α), causing β-catenin phosphorylation and its cytoplasmic retention [81].”
The Notch signaling pathway in desmoid tumor: Recent advances and the therapeutic prospects
Zheng, C., Huang, J., Xu, G., Li, W., Weng, X., & Zhang, S. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166907 · Cited by 11
Vasu, M., Ahlawat, S., Arora, R., & Sharma, R. (2025) · Mammalian Genome · doi:10.1007/s00335-025-10109-z · Cited by 11
“…genes responsible for hair follicle growth, regeneration, and overall hair cycling, serving as a central regulator for various hair cells, including dermal papilla cells, hair matrix cells, and outer root sheath cells (Kimelman and Xu 2006; Veltri et al. 2018; Doumpas et al. 2019; Choi 2020).”
Selvarathinam, K., Subramani, P., Thekkumalai, M., Vilwanathan, R., Selvarajan, R., & Abia, A. L. K. (2023) · Molecules · doi:10.3390/molecules28030930 · Cited by 11
“Without the Wnt ligand, glycogen synthase kinase-β (GSKβ) and casein kinase 1 phosphorylate β-catenin, accelerating its degradation via the ubiquitination pathway [17].”
BackgroundRiegert‐Johnson, D. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-28103-2_9 · Cited by 12
GSK-3 signaling is involved in proliferation of chicken primordial germ cells
Chen, D., Yang, M., Xie, L., Lu, Z., Mo, L., Yang, W., Sun, J., Xu, H., Ke-huan, L., Liao, Y., et al. (2019) · Theriogenology · doi:10.1016/j.theriogenology.2019.09.002 · Cited by 11
Tarnow, G., & McLachlan, A. (2021) · Journal of Virology · doi:10.1128/jvi.00780-21 · Cited by 11
Goretsky, T., Bradford, E. M., Ryu, H., Tahir, M., Moyer, M. P., Gao, T., Li, L., & Barrett, T. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.669416 · Cited by 11
Iyer, D., Mastrogiacomo, D. M., Li, K., Banerjee, R., Yang, Y., & Scallan, J. P. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319405 · Cited by 11
“22 The complex sequentially phosphorylates β -catenin, targeting it for polyubiquitination and proteasomal degradation.”
BackgroundMethodInfluentialRegulation of the Wnt signaling pathway during myogenesis by the mammalian SWI/SNF ATPase BRG1
Sharma, T., Olea‐Flores, M., & Imbalzano, A. N. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1160227 · Cited by 10
“…components (Figure 2), we therefore looked for interaction between BRG1 and BAF250A, a subunit of mSWI/SNF enzymes that is speci fi c to the BAF subfamily of mSWI/SNF complexes (Kimelman and Xu, 2006), and β -catenin, which promotes Wnt target gene expression when translocated to the nucleus.”
Katanaev, V. L., & Kryuchkov, M. (2011) · Biochemistry (Moscow) · doi:10.1134/s0006297911130116 · Cited by 11
Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD
Bethard, J. R., Zheng, H., Roberts, L. L., & Eblen, S. T. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.08.023 · Cited by 10
“GSK-3β phosphorylates β-catenin and promotes its degradation via ubiquitination by SCF β-TrCP and degradation by the proteosome [22,23].”
Backgroundβ-catenin involvement in arsenite-induced VEGF expression in neuroblastoma SH-SY5Y cells
Watcharasit, P., Suntararuks, S., Visitnonthachai, D., Thiantanawat, A., & Satayavivad, J. (2012) · Environmental Toxicology · doi:10.1002/tox.21794 · Cited by 10
“It is well established that b-catenin phosphorylation by GSK3 plays a major role in its degradation (Kimelman and Xu, 2006; MacDonald et al., 2009) so we examined whether arsenite affected activity of GSK3 in SH-SY5Y Fig.”
BackgroundInfluentialPhull, M. S., Jadav, S. S., Gundla, R., & Mainkar, P. S. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113149 · Cited by 10
Regulation of SUMOylation Targets Associated With Wnt/β-Catenin Pathway
Fan, L., Yang, X., Zheng, M., Yang, X., Ning, Y., Gao, M., & Zhang, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.943683 · Cited by 11
“This destructive complex include adenomatous polyposis coli (APC), glycogen synthase kinase 3b (GSK-3b), Axin, and casein kinase 1 (CK1), which promote ubiquitination-dependent degradation of phosphorylated bcatenin (30).”
BackgroundTumor cell-derived ANGPTL2 promotes β-catenin-driven intestinal tumorigenesis
Horiguchi, H., Kadomatsu, T., Yumoto, S., Masuda, T., Miyata, K., Yamamura, S., Sato, M., Morinaga, J., Ohtsuki, S., Baba, H., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02405-8 · Cited by 10
“In the absence of WNT signaling, β-catenin is phosphorylated by the β-catenin destruction complex, which is composed of adenomatous polyposis coli (APC), glycogen synthase kinase 3 (GSK3), AXIN, and casein kinase 1α (CK1α), and undergoes proteasomal degradation [1].”
BackgroundDKK1-targeting cholesterol-modified siRNA implication in hair growth regulation
Papukashvili, D., Liu, C., Rcheulishvili, N., Xie, F., Wang, X., Feng, S., Xiu, S., Zhang, C., Li, Y., He, Y., et al. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.05.047 · Cited by 9
Towards multiplexed protein–protein interaction analysis using protein tag-specific nanobodies
Groll, N., Emele, F. E., Poetz, O., & Rothbauer, U. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.04.017 · Cited by 9
Finnson, K. W., Kontogiannea, M., Li, X., & Farookhi, R. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.111.096396 · Cited by 9
“In the absence of a WNT signal, CTNNB1 is phosphorylated at N-terminal serine/ threonine residues by glycogen synthase kinase (GSK)-3beta, within a multiprotein ‘destruction complex’ that includes disheveled, axin and adenomatous polyposis coli, which targets CTNNB1 for ubiquitination and degradation by the proteosome…”
BackgroundOu, G., & Weaver, V. M. (2015) · BioEssays · doi:10.1002/bies.201500090 · Cited by 10
“In the absence of ligand-induced activation, b-catenin is phosphorylated and directed for ubiquitin-mediated degradation by the Axin complex, a process controlled by interactions with GSK3, CK1a, and APC [35, 36].”
Shikonin promotes osteogenesis and suppresses osteoclastogenesis in vitro.
Zhou, L., Wang, J., Zhao, J., Kuai, F., & Yang, H. (2020) · Europe PMC (PubMed Central) · Cited by 9
Depletion of Demethylase KDM6 Enhances Early Neuroectoderm Commitment of Human PSCs
Meng, Y., Zhang, T., Zheng, R., Ding, S., Yang, J., Liu, R., Jiang, Y., & Jiang, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.702462 · Cited by 8
Molecular cloning and characterization of the β-catenin gene from fine-wool sheep
Cui, K., Yang, Z., Darwish, H. Y. A., Zhang, Y., Ge, Y., Zhang, X., Li, R., & Deng, X. (2014) · Gene · doi:10.1016/j.gene.2014.05.067 · Cited by 9
“1 2 3Q1 4Q2 5 6 7 8 9 10 11 12 13 14 15 16 17 32 334 35 6 37 38 39 40 41 42 43 44 45 46 47 48 49 50 Gene xxx (2014) xxx–xxx GENE-39718; No. of pages: 6; 4C: Contents lists available at ScienceDirect Gene j ourna l homepage: www.e lsev ie r .com/ locate /gene Molecular cloning and characterization of the β-catenin gene…”
BackgroundChronic myeloid leukemia stem cells and developing therapies
Donato, N. J., & Peterson, L. F. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.546921 · Cited by 8
“GSK3b-mediated phosphorylation of b-catenin increases its ubiquitination and proteasomal turnover, thereby reducing expression of bcatenin regulated genes controlling cell cycle and survival [111].”
BackgroundCrosstalk of Hippo/YAP and Wnt/β-catenin pathways
Xu, F., Jin, Z., & Ma, D. (2014) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2014.00095 · Cited by 8
“[DOI] [16] Kimelman D, Xu W.”
Dadhania, V., Bhushan, B., Apte, U., & Mehendale, H. (2017) · Dose-Response · doi:10.1177/1559325817690287 · Cited by 10
Martins, C. S., Costa, D. V. D. S., Lima, B. B., Leitão, R. F. D. C., Freire, G. E., Silva, G. F. M., Pacífico, D. M., Abreu, J. G., & Brito, G. A. D. C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01998 · Cited by 8
“Then, nuclear β-catenin binds to the transcription factors of the T cell factor/lymphocyte enhancer factor (TCF/LEF) family (Kimelman and Xu, 2006; Ring et al., 2014) and promotes the transcription of Wnt/β-catenin pathway target genes, including cMYC, cyclin D1, survivin, bcl-2, Rac1, Rho, and…”
BackgroundWnt7b Inhibits Osteoclastogenesis via AKT Activation and Glucose Metabolic Rewiring
Wu, F., Li, B., Hu, X., Yu, F., Shi, Y., & Ye, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.771336 · Cited by 8
Rowling, P. J. E., Murton, B. L., Du, Z., & Itzhaki, L. S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.896493 · Cited by 8
“The BDC comprises five different proteins: two structural proteins, APC and axin, three kinases [glycogen synthase kinase 3β (GSK3β) and casein kinase 1α and casein kinase 1ε (CK1α, CK1ε)], and protein phosphatase 2A (PP2A).”
BackgroundInfluentialJawanjal, P., Salhan, S., Dhawan, I., Tripathi, R., & Rath, G. (2014) · PubMed · Cited by 8
Role of Wnt-p53-Nox Signaling Pathway in Cancer Development and Progression
Kumar, D., Sharma, S., Verma, S., Kumar, P., & Ambasta, R. K. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2015/17996 · Cited by 9
“While in absence of Wnt signals, destruction complex marks βcatenin for ubiquitination and subsequent degradation [19].”
BackgroundPark, S., Yoon, S., Kim, H., & Kim, K. K. (2016) · Neoplasia · doi:10.1016/j.neo.2016.08.006 · Cited by 8
“The N-terminus of β-catenin plays essential roles in Axin-, GSK3-, CK1-, and APC-mediated destruction of β-catenin [20].”
Backgroundunc-37/ Groucho and lsy-22/ AES repress Wnt target genes in C. elegans asymmetric cell divisionsPreprint
Bekas, K. N., & Phillips, B. T. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.10.475695 · Cited by 8
“In the unsignaled daughter cell resulting from a Wnt-polarized ACD, lack of Wnt ligand allows for the stabilized cytoplasmic destruction complex to phosphorylate β-catenin, ultimately leading to its proteasomal degradation (He et al., 2004; Kimelman & Xu, 2006; Logan & Nusse, 2004).”
BackgroundIntestinal Wnt in the transition from physiology to oncology
Swoboda, J., Mittelsdorf, P., Chen, Y., Weiskirchen, R., Stallhofer, J., Schüle, S., & Gaßler, N. (2022) · World Journal of Clinical Oncology · doi:10.5306/wjco.v13.i3.168 · Cited by 8
Targeting Moonlighting Enzymes in Cancer
Lin, C., Yu, M., Wu, X., Wang, H., Wei, M., & Zhang, L. (2024) · Molecules · doi:10.3390/molecules29071573 · Cited by 8
“GSK-3 plays a crucial role in maintaining the stability of this complex, thereby enabling coordinated phosphorylation of β -catenin [14,16].”
BackgroundChen, X., Liu, Y., Meng, B., Wu, D., Wu, Y., & Cao, Y. (2021) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2021.105111 · Cited by 7
Feng, S., Liu, H., Du, P., Dong, X., Pang, Q., & Guo, H. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-5707 · Cited by 7
The predictive value and correlation of β-catenin, CMTM6, and PD-L1 expression in colorectal cancer
Li, B., Wu, S., Qiu, Z., Zhong, X., Chen, Z., Luo, F., Li, J., & Liu, K. (2022) · Neoplasma · doi:10.4149/neo_2022_210809n1122 · Cited by 7
Bian, R., Zhao, J., Yao, Z., Cai, Y., Shou, C., Lou, D., Zhou, L., & Qian, Y. (2022) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-458 · Cited by 7
Yu, Y., Papukashvili, D., Ren, R., Rcheulishvili, N., Feng, S., Bai, W., Zhang, H., Xi, Y., Lu, X., & Xing, N. (2023) · Future Oncology · doi:10.2217/fon-2023-0227 · Cited by 7
Zhu, X., Wu, X., Cheng, J., Liao, H., Di, X., Li, L., Li, R., Zhou, Y., & Zhang, X. (2017) · Oncotarget · doi:10.18632/oncotarget.17766 · Cited by 7
Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells
Duchartre, Y., Kim, Y., & Kahn, M. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7027-8_18 · Cited by 7
Protein Phosphatase Signaling in Cardiac Myocytes
Abdallah, D., Malhotra, N., & Refaey, M. E. (2022) · Springer eBooks · doi:10.1007/978-3-031-08309-9_5 · Cited by 6
Zhang, T., Chen, H., Zhou, Y., Dong, W., Cai, H., & Tan, W. (2019) · Bioresources and Bioprocessing · doi:10.1186/s40643-019-0249-5 · Cited by 6
“2006; Kimelman 2006; MacDonald and He 2009).”
c-Met as a potential therapeutic target in triple negative breast cancer
Chaudhary, S. S., Choudhary, S., Rawat, S., Ahir, G., Bilgrami, A. L., & Ashraf, G. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818168-3.00011-5 · Cited by 5
Patel, S., McCormack, C. C., & Hodge, J. C. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206432 · Cited by 6
Liu, S., Li, S., Yu, X., Wang, Q., & Sun, H. (2020) · PubMed Central · Cited by 6
Bala, P., Kavadipula, P., Sarkar, S., & Bashyam, M. D. (2022) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-022-00886-0 · Cited by 6
Our evolving view of Wnt signaling in C. elegans
Robertson, S. M., & Lin, R. (2012) · Worm · doi:10.4161/worm.19156 · Cited by 6
Nuclear GSK ‐3β segregation in desmoid‐type fibromatosis
Meneghello, C., Ousghir, B., Rastrelli, M., Anesi, L., Sommariva, A., Montesco, M. C., Rossi, C. R., Hladnik, U., & Segat, D. (2013) · Histopathology · doi:10.1111/his.12133 · Cited by 6
“To further investigate the almost exclusively nuclear localization of GSK-3b and b-catenin, we extended the studies to APC and axin, which are known to be critical for b-catenin regulation.(18,20,26) For this purpose, we performed double immunofluorescence labelling in DF and control cells with antibodies against APC…”
BackgroundSmith, B. M., Rowling, P. J. E., Dobson, C. M., & Itzhaki, L. S. (2021) · Biomolecules · doi:10.3390/biom11060827 · Cited by 6
“The BDC comprises five different proteins: two structural proteins Axin and adenomatous polyposis coli (APC), two kinases (glycogen synthase kinase 3β (GSK3β) and casein kinase 1α (CK1α)) and protein phosphatase 2A (PP2A).”
BackgroundLiu, C., Yao, M., & Hogue, C. W. V. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-s13-s13 · Cited by 6
“Phosphorylated LRP6 recruits AXIN resulting in the disruption of the " b-catenin destruction complex " , which comprises AXIN, APC (the tumor suppressor Adenomatous polyposis coli), GSK3 and CK1a [9] [10].”
BackgroundHuman‐Centric, Three Dimensional Micro Light‐Emitting Diodes for Cosmetic and Medical Phototherapy
Nam, K. Y., Kim, M. S., An, J., Min, S., Lee, J. H., Park, J. S., Huh, C., Yun, S. H., & Lee, K. J. (2025) · Advanced Science · doi:10.1002/advs.202416716 · Cited by 5
Formation of Tankyrase Inhibitor-Induced Degradasomes Requires Proteasome Activity
Pedersen, N. M., Thorvaldsen, T. E., Schultz, S. W., Wenzel, E. M., & Stenmark, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160507 · Cited by 5
“The core components of the destruction complex consist of Ade-nomatous Polyposis Coli (APC), axis inhibition protein 1 and 2 (AXIN1 and AXIN2) and the kinases glycogen synthase kinase 3 (GSK3) and casein kinase 1 α (CK1 α ) [2, 3].”
Wnt/β-catenin signaling regulates pathogenesis of human middle ear cholesteatoma.
Lin, J., Ye, Q., Wang, Y., Wang, Y., & Zeng, Y. (2019) · Europe PMC (PubMed Central) · Cited by 5
Kaiser, A., Eiselt, G., Bechler, J., Huber, O., & Schmidt, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054654 · Cited by 5
“Only phosphorylated β-catenin is ubiquitinylated (U) by E3 ubiquitin ligase β-Trcp (β-Trcp), leading to proteasomal degradation [54].”
BackgroundYao, C., Tao, H.-T., He, J.-J., Zhu, F.-Y., Xie, C.-Q., Cheng, Y.-N., Li, J.-Q., Liu, Z.-Z., Hou, C., Liu, X., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01088-7 · Cited by 5
Gottlieb, S., van der Vaart, A. D., Hassan, A., Bledsoe, D., Morgan, A., O'Rourke, B., Rogers, W. D., Wolstenholme, J. T., & Miles, M. F. (2025) · Addiction Biology · doi:10.1111/adb.70044 · Cited by 5
Layton, M. J., Faux, M. C., Church, N. L., Catimel, B., Kershaw, N. J., Kapp, E. A., Nowell, C. J., Coates, J. L., Burgess, A. W., & Simpson, R. J. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.03.006 · Cited by 5
Development of structure-based pharmacophore to target the β-catenin-TCF protein–protein interaction
Pagare, P. P., Morris, A., Li, J., & Zhang, Y. (2021) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02693-3 · Cited by 5
OptoLRP6 Illuminates Wnt Signaling in Early Embryo Development
Garabedian, M. V., & Good, M. C. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167053 · Cited by 5
“9 When cells are stimulated by the Wnt ligand binding to Frz and LRP6, components of the destruction complex translocate to the membrane and are downregulated, thus stabilizing b -catenin.”
BackgroundZhu, X., Gao, H., Qin, S., Liu, D., Cairns, J., Gu, Y., Yu, J., Weinshilboum, R. M., & Wang, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1047318 · Cited by 5
“Specifically, β-catenin is a downstream target of Wnt signaling (Kimelman and Xu, 2006).”
BackgroundEsmatabadi, M. J. D., Sarkandi, M., Zade, H. M., Khaledi, G., Montazeri, M., Shekarabi, H. S. Z., Hormoz, Y. A., & Asgari, E. A. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 5
Ruling Out a Suspect: the Role of β-Catenin Mutation in Benign Parathyroid Neoplasia
Simonds, W. F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0314 · Cited by 5
Metadata
- Authors
- Kimelman, D., & Xu, W.
- Affiliations
- University of Washington (US)
- Corresponding author
- Kimelman, D
- ORCID
- Venue
- Oncogene
- Published
- 2006-12-04
- Volume
- 25
- Issue
- 57
- Pages
- 7482-7491
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2072335762
- Cited by
- 628
- References
- 72
- Citations by year
- 2026: 8 · 2025: 21 · 2024: 23 · 2023: 27 · 2022: 41 · 2021: 52 · 2020: 19 · 2019: 25 · 2018: 37 · 2017: 40 · 2016: 28 · 2015: 36 · 2014: 51 · 2013: 33 · 2012: 40
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA 90351, R01CA090351)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD027262, HD27262)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- β-catenin destruction complex, Wnt/β-catenin signaling, β-catenin phosphorylation, β-catenin ubiquitination, protein complex structure, Wnt signaling inhibition
- MeSH terms
- Animals, Cell Nucleus, Colonic Neoplasms, Cytosol, Humans, Models, Biological, Phosphorylation, Protein Conformation, Stem Cells, Ubiquitin, beta Catenin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review